ArticlePloS one2025

The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASH.

Jenny Norlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.